Barclays’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,328
Closed -$38K 5320
2021
Q4
$38K Hold
1,328
﹤0.01% 3871
2021
Q3
$50K Sell
1,328
-119
-8% -$4.64K ﹤0.01% 4109
2021
Q2
$66K Buy
1,447
+119
+9% +$5.07K ﹤0.01% 4011
2021
Q1
$52K Hold
1,328
﹤0.01% 4190
2020
Q4
$52K Buy
+1,328
New +$47K ﹤0.01% 4382

Other funds holding KURE

Barclays's KURE Position: Q1 2022 in Review

Barclays sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q1 2022, closing a stake of 1,328 shares — an estimated $38K sold.

Barclays first reported a position in KURE in Q4 2020 and held it in 5 quarters. The position peaked at $66K in Q2 2021. 22 funds tracked by Wall St. Rank hold KURE as of Q1 2022.

  • Barclays reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q1 2022 after selling out during the quarter.
  • Barclays sold 1,328 KraneShares MSCI All China Health Care Index ETF shares in Q1 2022, an estimated $38K.
  • Barclays first reported a position in KraneShares MSCI All China Health Care Index ETF in Q4 2020 and held it in 5 quarters.
  • Barclays's KraneShares MSCI All China Health Care Index ETF position peaked at $66K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q1 2022.

Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.